ALEXANDRIA, Va. – The National Community Pharmacists Association and the American Pharmacists Association announced Thursday that they have voluntarily dismissed a lawsuit dating back to the previous administration. The two groups were the lead plaintiffs in the federal case against the secretary of HHS. “We’ve been fighting in Congress for years to end retroactive pharmacy
WASHINGTON — Scott Knoer, executive vice president and CEO of the American Pharmacists Association has issued the following statement on President-Elect Biden’s plan to address COVID-19: “President-Elect Biden’s plan to address COVID-19 is a strong start to rescue the country from the pandemic. It not only allocates billions of dollars to launch a sweeping national plan
WASHINGTON — The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration’s approval of the first Emergency use Authorization for the COVID-19 vaccine. “We heartily welcome the decision by the US Food and Drug Administration (FDA) to authorize the emergency use of the first COVID-19 vaccine, following the
WASHINGTON — All pharmacists should be in the first tier of providers for receiving the COVID-19 vaccine to ensure that pharmacists are able to continue providing critical care to their patients, said Scott Knoer, in testimony this week to a committee of the National Academies of Science, Engineering and Medicine. The academy’s draft recommendations placed pharmacists
ALEXANDRIA, Va. – The fastest and surest way to immunize millions of Americans against COVID-19 is to enlist local pharmacists who see more patients per year than primary physicians, a group of national pharmacy organizations told the National Governors Association today. “To realize the positive outcomes hoped for, all community-based pharmacists and pharmacies must be part of
ALEXANDRIA, Va. – The country’s leading pharmacy groups said that any action on a prescription drug rebate rule must address skyrocketing fees extracted by pharmacy benefit managers on behalf of plan sponsors in Medicare Part D. “We remind the Administration of the continuous and heightened impact of pharmacy DIR fees imposed by Medicare Part D
ALEXANDRIA, Va. – The Alliance for Pharmacy Compounding, American Pharmacists Association, American Society of Consultant Pharmacists, National Alliance of State Pharmacy Associations, and National Community Pharmacists Association collectively urged “reinvigorated and reimagined antitrust enforcement policy” in joint comments submitted Wednesday to the Federal Trade Commission and the Department of Justice Antitrust Division. Earlier this year,
WASHINGTON — Pharmacy Profiles, the trusted and verified repository of the nation’s pharmacist providers, announced Tuesday its nationwide launch. A subsidiary of the American Pharmacists Association, Pharmacy Profiles provides a one-stop repository of all of the professional information a pharmacist would need to achieve and maintain full recognition as a health care provider. It will
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Today, pharmacists are facing a health care environment that presents both opportunities and challenges. On one hand, there are opportunities as the health care system shifts to value-based payment and other health care providers increasingly recognize that utilization of pharmacists
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) has partnered with the American College of Obstetricians and Gynecologists (ACOG) and the American Pharmacists Association (APhA) to create a tip sheet for obstetricians and gynecologists to implement an immunization referral system with other healthcare stakeholders, including pharmacies. Obstetrician-gynecologists and pharmacists, including NACDS member
WASHINGTON — A group of senators are sponsoring legislation to bring more prescription drug pricing transparency to the pharmacy counter. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) yesterday introduced the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), which would
WASHINGTON— Opioid abuse is a serious public health problem that has reached crisis levels across the United States, with more than 90 Americans dying each day from overdose of opioids, and many more becoming addicted. Recognizing the urgency and impact of this issue on the health of millions of patients across the country, a coalition
WASHINGTON — The American Pharmacists Association (APhA) Foundation has partnered with The Kroger Co. and Solera Health for a program to help reduce the incidence of diabetes through community pharmacies. Under the project, called “Project IMPACT: Diabetes Prevention,” the APhA Foundation was selected by the Centers for Disease Control and Prevention (CDC) to build infrastructure
WASHINGTON — The American Pharmacists Association (APhA) has unveiled the Leadership360 Institute, an educational program to help pharmacists enhance their leadership and management skills. Institute participants can sign up for any or all of the three Leadership tracks, including Lead360, Mentor360 and Manage360. Each track will offer programs to help pharmacists excel in their individual
